I'm a pharmacist (PhD) and Medical Affairs Leader with over a decade of experience in oncology. From research at the University of Nagoya to leading medical strategies at a top pharmaceutical company, I build systems at the intersection of clinical science, AI, and patient outcomes.
Over 10 years of driving medical strategy, digital transformation, and patient-centered innovation in oncology.
Leading integrated medical strategies in lung cancer across Germany. Five successful product launches, omnichannel engagement strategies, and cross-functional team leadership spanning Medical, Regulatory, and Market Access.
Building digital tools, dashboards, and agentic AI workflows that increase productivity across Medical Affairs teams. Championing AI adoption within the organization and exploring how large language models transform how we engage with healthcare professionals.
Spearheaded the development of brustkrebs.de — a patient information platform helping breast cancer patients better understand their diagnosis, treatment options, and care pathway.
My career began in pharmaceutical research — earning a PhD in Pharmacy (Magna Cum Laude) from the University of Münster, with a research fellowship at the University of Nagoya in Japan. That foundation in rigorous science shaped how I approach everything I do today.
I transitioned into the pharmaceutical industry as a Medical Science Liaison, first at Bayer in cardiovascular medicine, then at AstraZeneca in solid tumor oncology. Over the years, I advanced to Medical Affairs Manager, then Lead — driving medical strategy for breast cancer therapies and now for lung cancer.
What sets me apart is my conviction that Medical Affairs must evolve. I don't just manage medical plans — I build systems. Whether it's designing AI-powered workflows that save hundreds of hours, creating patient education platforms, or developing data dashboards that enable smarter decisions, I believe in leveraging technology to amplify the impact of medical science.
I regularly speak at internal summits and industry events on topics ranging from AI adoption in Medical Affairs to the future of omnichannel engagement in oncology. My goal is to inspire teams to think differently about how we deliver medical value.
University of Münster · University of Nagoya, Japan
Magna Cum Laude. Research in pharmaceutical sciences with an international fellowship at Nagoya University.
Bayer · Cardiovascular Medicine
Field medical work with Key Opinion Leaders in the cardiovascular & renal space.
AstraZeneca · Head & Neck, GI, GU Cancers
Managing a team of Medical Science Liaisons across multiple solid tumor indications.
AstraZeneca · Oncology
Five product launches. Omnichannel medical strategies. Created brustkrebs.de. Promoted to Medical Affairs Lead.
AstraZeneca · NSCLC Germany
Strategic leadership for advanced lung cancer therapies. Leading a team of 4 Medical Affairs Managers. AI innovation champion. Building digital tools and agentic workflows for Medical Affairs.
Reflections on AI, Medical Affairs, and the evolving oncology landscape.
The era of copy-pasting data into spreadsheets is over. How agentic workflows are transforming the way Medical Affairs teams operate, from event tracking to KOL engagement.
The role of the Medical Advisor is changing faster than most realize. A look at the skills, mindset, and tools that will define the next generation of medical affairs professionals.
What I learned from developing a patient information platform from scratch — and why pharma companies should invest more in digital patient engagement.